Compare Eli Lilly And Co (LLY) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Wheaton Precious Metals Corp — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Wheaton Precious Metals Corp trades at $138.65 (market cap $61.17B). The key difference: Eli Lilly And Co is far larger — about 17× Wheaton Precious Metals Corp's market cap, and Eli Lilly And Co pays the higher dividend (0.59%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Wheaton Precious Metals Corp for 66 Days on average.
| LLY | WPM | |
|---|---|---|
Market Cap | $1.04T | $61.17B |
Volume | 3,064,878 | 1,092,361 |
Sector | Health | Basic Materials |
52-Week High | $1.28K | $165.72 |
52-Week Low | $799.57 | $94.37 |
Typical Hold Time | 93 Days | 66 Days |
Enterprise Value | $1.09T | $63.05B |
Dividend Yield | 0.59% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
Wheaton Precious Metals (WPM) trades at $134.96, up 0.95% today, with a bearish technical signal despite recent earnings beats. The company reported record 2025 revenue of $2.31 billion and net income of $1.47 billion, supported by strong profitability margins. Management targets 50% production growth by 2030 through streaming deals without new capital, as highlighted in recent investor events.
WPM presents a growth opportunity with a robust streaming model and fully funded pipeline, but faces risks from gold price volatility and high valuations. Analyst consensus is bullish with an $164.80 price target, though technical indicators suggest near-term caution. Upside depends on execution of expansion plans amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
